ID: ALA30128

Max Phase: Preclinical

Molecular Formula: C9H12N5O5P

Molecular Weight: 301.20

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Nc1ncnc2c1ncn2OC(/C=C/P(=O)(O)O)CO

Standard InChI:  InChI=1S/C9H12N5O5P/c10-8-7-9(12-4-11-8)14(5-13-7)19-6(3-15)1-2-20(16,17)18/h1-2,4-6,15H,3H2,(H2,10,11,12)(H2,16,17,18)/b2-1+

Standard InChI Key:  IDOLXIZHUZCUIL-OWOJBTEDSA-N

Associated Targets(non-human)

Visna-maedi virus 44 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 301.20Molecular Weight (Monoisotopic): 301.0576AlogP: -1.11#Rotatable Bonds: 5
Polar Surface Area: 156.61Molecular Species: ACIDHBA: 8HBD: 4
#RO5 Violations: 0HBA (Lipinski): 10HBD (Lipinski): 5#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.54CX Basic pKa: 1.52CX LogP: -2.30CX LogD: -4.62
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.50Np Likeness Score: 0.49

References

1. Harnden MR, Parkin A, Parratt MJ, Perkins RM..  (1993)  Novel acyclonucleotides: synthesis and antiviral activity of alkenylphosphonic acid derivatives of purines and a pyrimidine.,  36  (10): [PMID:8496903] [10.1021/jm00062a006]

Source